Answer:
<u><em>The answer is</em></u>: <u>Diagnostic code ICD-10-CM 2019 I50.2 Systolic (congestive) heart failure.</u>
<u />
Explanation:
Heart failure (HF) with reduced ejection fraction <em>is responsible for approximately 50% of cases of heart failure in the U.S. and it is associated with considerable morbidity and decreased quality of life.
</em>
<u><em>Diagnostic code ICD-10-CM 2019 I50.2 Systolic (congestive) heart failure</em></u>, applicable to Heart failure with reduced ejection fraction [HFrEF].
<u><em>The answer is</em></u>: <u>Diagnostic code ICD-10-CM 2019 I50.2 Systolic (congestive) heart failure.</u>
Answer:
I believe the code is E11.31.
Explanation:
Type 2 diabetes mellitus with unsp diabetic retinopathy. Code for that is E11.31.
A Drug Trend report published in 2009 had predicted continued price increase among traditional branded and biotech drugs that lack generic competition. Now, further, CMS has reduced its Average Sales price (ASP) margin from 6 percent to 4 percent for non-pass-thorough. This has affected pharmacy reimbursement. However, there are certain other aspects of Pharmacy Billing that can affect reimbursement and thereby the Revenue Cycle Management (RCM) process if not well implemented.
1. Data Workflow:
Recognizing how the revenue cycle works in pharmacy is very essential. Procurement to Inventory, billing and reimbursement involves purchase of medications, their storage, and method of dispensing, how they are administered, way they are coded & billed, and finally reimbursed. If the drug is covered as a pharmacy benefit, or the payer needs that to be obtained via a specialty pharmacy as identified through patient-specific benefit verification, then here both the provider and the pharmacy are part of the reimbursement process. The physician writes a prescription and orders the drug. This is followed by the pharmacy that fills the order and issues the drug to the physician, CMHC, or hospital outpatient department. Here the pharmacy bills the insurance company for the drug. If any information is entered incorrectly into the pharmacy system in the initial phase of the cycle, errors can prove to be costly, impacting aspects of clinical and revenue cycle.
2. Procurement:
During this phase information is converted from purchased quantities and pricing to storage units of measure (UOM) and inventory costs. Manually entering the data is followed in most cases. UOM conversions, when data is uploaded from the wholesale distributor to the pharmacy system, are also checked and verified manually. Here too mistakes can lead to breakdown in the revenue cycle management (RCM) process.
3. The Charge master:
Critical & substantial revenue leakage can occur when separately reimbursable medications are either missing from or miscoded in the charge master. Conversion of pharmaceutical quantities is a must from purchased amounts to patient-administered amounts, and only then made billable. There is often a difference between dosage amounts required for patient use as from that purchased. Besides inventory, the clinician and pharmacist should convert dosage, strength, and delivery mechanism for each drug. Drug data must be correctly converted from the quantities residing in clinical systems into the payer-billable quantities appropriate for the financial system or charge master. The UOMs must be reconciled to avoid any under- or over-payments. More than often, missing or incorrect data in the charge master can result in negative financial consequences – denied claims, partial reimbursement, and compliance risks.
4. Linkages between Purchases & Billing:
Most hospitals have separate processes to order drugs, administer them, and process reimbursement. Without linkage between pharmacy expenditures for medications (i.e., spend data) and the charge master, ensuring proper charge capture and optimal reimbursement is a challenge. Besides hospitals should have automated tools to identify charge capture errors precisely, so as to pinpoint when and where their occurrence to decreasing revenue loss.
Answer:
Your independent variable is the dosage.
Your DEPENDENT variable is the progression of the disease.
good luck<3
The best answer for the nurse to give is "You will be sedated but not asleep." Persons who are undergoing cardiac catheterization will receive a sedative but are not put to sleep. Their cooperation is needed during the procedure.
<h3>What is cardiac catheterization?</h3>
- During a cardiac catheterization procedure, a thin, flexible tube (catheter) is directed into a blood vessel to the heart in order to identify or treat certain heart disorders, such as blocked arteries or irregular heartbeats.
- The most common reason for performing this operation is to learn more about the heart or its blood arteries.
- Additionally, it could be carried out to determine whether you require heart surgery or to treat specific heart diseases.
- Cardiovascular catheterization may be used by your doctor to identify or assess: Cardiomyopathy or congestive heart failure causes.
- It takes a week or less for full recovery. For 24 to 48 hours, keep the region dry where the catheter was implanted. The recuperation process is frequently quicker if the catheter was placed into your arm.
To learn more about cardiac catheterization, refer to:
brainly.com/question/4562718
#SPJ4
